Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death-Reference-Cited by-同舟云学术

Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death

Published:2023-04 Issue:4 Volume:23 Page:559-564
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Keller Michael^ORCID,Yang Song,Ponor Lucia,Bon Ann,Cochrane Adam,Philogene Mary^ORCID,Bush Errol^ORCID,Shah Pali,Mathew Joby,Brown Anne W.^ORCID,Kong Hyesik^ORCID,Charya Ananth^ORCID,Luikart Helen^ORCID,Nathan Steven D.^ORCID,Khush Kiran K.^ORCID,Jang Moon,Agbor-Enoh Sean^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference22 articles.

1. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome;Palmer;Transplantation,2002

2. Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients;Snyder;Chest,2013

3. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection;Girnita;J Heart Lung Transplant,2004

4. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction;Girnita;Am J Transplant,2005

5. Human leukocyte antigens antibodies after lung transplantation: primary results of the HALT study;Hachem;Am J Transplant,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor Specific Antibodies in Extracorporeal Membrane Oxygenation-Bridged Lung Transplant Recipients;Annals of Thoracic Surgery Short Reports;2024-07

2. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction;American Journal of Transplantation;2024-06

3. Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation;Transplant International;2024-05-08

4. The diagnosis and management of chronic lung allograft dysfunction;Current Opinion in Pulmonary Medicine;2024-02-02

5. Acute Rejection of the Lung Allograft: Phenotypes and Management;OBM Transplantation;2023-11-21